StockData
vTv Therapeutics Inc. logo

vTv Therapeutics Inc. (VTVT) stock

VTVTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3062% below fair value
$17.29−0.40 (-2.26%)

Close on Nov 17, 2026Market cap $68.37MP/E –Yield –

vTv Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

vTv Therapeutics's total debt was $0 at Dec 31, 2024. For fiscal 2024 it was $0. The highest annual figure on record is $15.32M in fiscal 2017.

Annual total debt

PeriodPeriod endValueChange
FY2024Dec 31, 2024$0–
FY2023Dec 31, 2023$0–
FY2022Dec 31, 2022$0-100.0%
FY2021Dec 31, 2021$256.00K+204.8%
FY2020Dec 31, 2020$84.00K-41.7%
FY2019Dec 31, 2019$144.00K-97.8%
FY2018Dec 31, 2018$6.55M-57.3%
FY2017Dec 31, 2017$15.32M+38.5%
FY2016Dec 31, 2016$11.06M+388.2%
FY2014Dec 31, 2014$2.27M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024$0-100.0%
Q4 FY2023Dec 31, 2023$0-100.0%
Q4 FY2022Dec 31, 2022$0-100.0%
Q4 FY2021Dec 31, 2021$256.00K-85.1%
Q4 FY2020Dec 31, 2020$84.00K-96.2%
Q3 FY2020Sep 30, 2020$334.00K-91.7%
Q4 FY2019Dec 31, 2019$144.00K-97.8%
Q3 FY2019Sep 30, 2019$1.72M-81.0%
Q2 FY2019Jun 30, 2019$2.19M-79.9%
Q1 FY2019Mar 31, 2019$4.01M-69.3%
Q4 FY2018Dec 31, 2018$6.55M-57.3%
Q3 FY2018Sep 30, 2018$9.04M-47.5%
Q2 FY2018Jun 30, 2018$10.86M-41.3%
Q1 FY2018Mar 31, 2018$13.09M-30.2%
Q4 FY2017Dec 31, 2017$15.32M+38.5%
Q3 FY2017Sep 30, 2017$17.23M–
Q2 FY2017Jun 30, 2017$18.52M–
Q1 FY2017Mar 31, 2017$18.76M–
Q4 FY2016Dec 31, 2016$11.06M–

More vTv Therapeutics figures

See a number that looks wrong?